Global Application Practice | EClinCloud eCOA Supports International Multicenter Studies

With extensive experience and leading technology, the EClinCloud eCOA solution is supporting a growing number of international multicenter clinical trials and further improving study efficiency.
In recent years, many Chinese pharmaceutical companies have been actively pursuing global development for innovative drugs. Compared with the domestic market, international multicenter trials require more advanced technical support, a thorough understanding of target-market regulations, and efficient execution of trial plans. During
eCOA implementation, challenges include:
How should protocols be designed and planned across different time zones?
How are multiple languages for different trial participants addressed?
How is compliance ensured for cross-border data transfers?
……
Backed by the international experience of its global team and solid technical safeguards, EClinCloud eCOA sets the security protection and efficient management of all user data as its primary objective, providing strong support for partners' clinical studies worldwide:
1. The system strictly complies with domestic and international laws and regulations [including, but not limited to, the Data Security Law of the People's Republic of China, the Cybersecurity Law of the People's Republic of China, the Measures for the Security Assessment of Outbound Data Transfers, the Personal Information Protection Law, the Health Insurance Portability and Accountability Act (HIPAA) (United States), and the General Data Protection Regulation (GDPR) (European Union)], classifies data by information level, and establishes corresponding protection policies by level, such as masked data display and underlying encrypted log storage;
2. Supports dual domestic and overseas server storage and optional hardware device configurations;
3. Both the web and app versions support unrestricted global network access, ensuring smooth operation worldwide;
4. Multilingual coverage, supporting compatibility with the primary languages of trial participant groups across different languages;
5. Support for comparing records across global time zones and designing visit rules across different time zones, among other capabilities.
In addition, the EClinCloud
eCOA system is built on security technologies such as secure multi-party computation, federated learning, and security sandboxes. Through multi-portal integration, it fully connects the respective workflows of multiple stakeholder groups—including trial participants, investigators, sponsors, and CROs—establishing a full-chain, closed-loop data governance system based on the eCOA system that effectively safeguards data flow, effectiveness, authenticity, and accuracy within the clinical trial data-collection ecosystem.
In the future, EClinCloud will continue to support innovative pharmaceutical companies in their international exploration, further optimizing clinical trial data and insights and improving R&D efficiency to meet patient needs.

